A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation

BACKGROUND: Patients with hepatocellular carcinoma waiting for liver transplantation are commonly treated with locoregional treatments, such as TACE and ablation, to prevent tumor progression and dropout and to improve long-term outcome after transplantation. We wanted to prospectively assess feasib...

Descripción completa

Detalles Bibliográficos
Autores principales: Eilard, Malin Sternby, Andersson, Mats, Naredi, Peter, Geronymakis, Charalampos, Lindnér, Per, Cahlin, Christian, Bennet, William, Rizell, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560824/
https://www.ncbi.nlm.nih.gov/pubmed/31185950
http://dx.doi.org/10.1186/s12885-019-5760-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560824/
https://www.ncbi.nlm.nih.gov/pubmed/31185950
http://dx.doi.org/10.1186/s12885-019-5760-8

Ejemplares similares